Novel Orally Active Analgesic and Anti-Inflammatory Cyclohexyl-N-Acylhydrazone Derivatives

By Silva Tiago Fernandes da   Bispo Júnior Walfrido   Alexandre-Moreira Magna Suzana   Costa Fanny Nascimento   Monteiro Carlos Eduardo da Silva   Furlan Ferreira Fabio   Barroso Regina Cely Rodrigues   Noël François   Sudo Roberto Takashi   Zapata-Sudo Gisele   Lima Lídia Moreira   Barreiro Eliezer J.  

Molecules, Vol. 20, Iss. 2, 2015-02 ,pp. : 3067-3088

MDPI

Access to resources Recommend Favorite

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue

By Spadaccini Marco   D’Alessio Silvia   Peyrin-Biroulet Laurent   Danese Silvio  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1276-1276

MDPI

Access to resources Recommend Favorite

Discovery of (2-Fluoro-Benzyl)-(2-Methyl-2-Phenethyl-2H-Chromen-6-yl)-Amine (KRH-102140) as an Orally Active 5-Lipoxygenase Inhibitor with Activity in Murine Inflammation Models

By  

Pharmacology, Vol. 87, Iss. 1-2, 2011-01 ,pp. : 49-55

Karger

Access to resources Recommend Favorite

Inhibitory Effect of the New Orally Active CCR4 Antagonist K327 on CCR4+CD4+ T Cell Migration into the Lung of Mice with Ovalbumin-Induced Lung Allergic Inflammation

By  

Pharmacology, Vol. 84, Iss. 3, 2008-08 ,pp. : 171-182

Karger

Access to resources Recommend Favorite

Modulatory Effect of the PDE-5 Inhibitor Sildenafil in Diabetic Neuropathy

By  

Pharmacology, Vol. 72, Iss. 3, 2004-10 ,pp. : 190-195

Karger

Access to resources Recommend Favorite